Product Information
SUBVENITE 200 MG TABLET is a generic product labeled by OWP Pharmaceuticals, Inc., priced at $0.0840 per EA under NDC 69102032001. Its NADAC has been published 418 times since Aug 22, 2018.
FDA first approved this application on Jan 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the LAMOTRIGINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
OWP Pharmaceuticals, Inc.NDC
69102032001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA078947FDA Approved
1/27/2009
TE Code
AB
On Market Since
3/10/2018
Pharmacological Classes
Price Statistics
The NADAC for SUBVENITE 200 MG TABLET has been published 418 times since Aug 22, 2018, and over the history we have for it it has risen 14.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0840 per EA |
|---|---|
| All-time high | $0.1026 (Jun 15, 2022) |
| All-time low | $0.0597 (Jul 17, 2024) |
| 52-week high | $0.0846 |
| 52-week low | $0.0787 |
| Median price | $0.0795 |
| Average price | $0.0815 |
| Largest weekly change | +53.2% (Aug 21, 2024) |
| Weeks tracked | 418 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUBVENITE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUBVENITE 200 MG TABLET, manufactured by OWP Pharmaceuticals, Inc., is $0.0840 per EA (NDC 69102032001), effective Aug 19, 2026.
How has the price of SUBVENITE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUBVENITE 200 MG TABLET has risen 14.4%. It has been tracked across 418 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for SUBVENITE 200 MG TABLET?
Since Aug 22, 2018, the NADAC for SUBVENITE 200 MG TABLET has ranged from a low of $0.0597 (Jul 17, 2024) to a high of $0.1026 (Jun 15, 2022), with a median of $0.0795 per EA.
Are there cheaper alternatives to SUBVENITE 200 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUBVENITE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SUBVENITE 200 MG TABLET?
SUBVENITE 200 MG TABLET (NDC 69102032001) is labeled by OWP Pharmaceuticals, Inc., and CMS classifies it as a generic product.